Cargando…

Managing Cancer Drug Resistance from the Perspective of Inflammation

The development of multidrug resistance in cancer chemotherapy is a major obstacle to the effective treatment of human malignant tumors. Several epidemiological studies have demonstrated that inflammation is closely related to cancer and plays a key role in the development of both solid and liquid t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Shuaijun, Li, Yang, Zhu, Changling, Wang, Weihua, Zhou, Yuping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553519/ https://www.ncbi.nlm.nih.gov/pubmed/36245983 http://dx.doi.org/10.1155/2022/3426407

Ejemplares similares

Surmounting Cancer Drug Resistance: New Perspective on RNA-Binding Proteins
por: Feng, Yiyuan, et al.
Publicado: (2023)

A perspective profile of ADCY1 in cAMP signaling with drug-resistance in lung cancer
por: Zou, Ting, et al.
Publicado: (2019)

Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management
por: Jin, Ping, et al.
Publicado: (2022)

Managing therapeutic resistance in breast cancer: from the lncRNAs perspective
por: Peng, Liyuan, et al.
Publicado: (2020)

Inflammation management in acute diverticulitis: current perspectives
por: Ceresoli, Marco, et al.
Publicado: (2018)

HIV Drug Resistance: Problems and Perspectives
por: Pennings, Pleuni S.
Publicado: (2013)

Perspectives of metal-organic framework nanosystem to overcome tumor drug resistance
por: Wang, Huafeng, et al.
Publicado: (2022)

Advances in Drug Resistance of Esophageal Cancer: From the Perspective of Tumor Microenvironment
por: Luan, Siyuan, et al.
Publicado: (2021)

Histone modifications in drug-resistant cancers: From a cancer stem cell and immune evasion perspective
por: Jin, Ming Li, et al.
Publicado: (2023)

Perspectives of nano-carrier drug delivery systems to overcome cancer drug resistance in the clinics
por: Ulldemolins, Anna, et al.
Publicado: (2021)

Drug-induced oxidative stress in cancer treatments: Angel or devil?
por: Jiang, Hao, et al.
Publicado: (2023)

Laser-activatable oxygen self-supplying nanoplatform for efficiently overcoming colorectal cancer resistance by enhanced ferroptosis and alleviated hypoxic microenvironment
por: Jiang, Hao, et al.
Publicado: (2023)

Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives
por: Saunders, Nicholas A, et al.
Publicado: (2012)

Nanomedicine Strategies for Management of Drug Resistance in Lung Cancer
por: Haider, Mohamed, et al.
Publicado: (2022)

Responding to the emergence of antifungal drug resistance: perspectives from the bench and the bedside
por: Beardsley, Justin, et al.
Publicado: (2018)

Opioid analgesics-related pharmacokinetic drug interactions: from the perspectives of evidence based on randomized controlled trials and clinical risk management
por: Feng, Xiu-qin, et al.
Publicado: (2017)

Drug resistance and combating drug resistance in cancer
por: Wang, Xuan, et al.
Publicado: (2019)

Accurate Wheat Lodging Extraction from Multi-Channel UAV Images Using a Lightweight Network Model
por: Yang, Baohua, et al.
Publicado: (2021)

Phase Change Materials Application in Battery Thermal Management System: A Review
por: Liu, Changcheng, et al.
Publicado: (2020)

Perspective: APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution
por: Venkatesan, S, et al.
Publicado: (2018)

Management of Antibiotic-Resistant Helicobacter pylori Infection: Perspectives from Vietnam
por: Van Khien, Vu, et al.
Publicado: (2019)

Why nanodiamond carriers manage to overcome drug resistance in cancer
por: Benson, Veronika, et al.
Publicado: (2020)

Multidrug and extensively drug-resistant tuberculosis from a general practice perspective
por: Yashodhara, BM, et al.
Publicado: (2010)

Exosomes in Genitourinary Cancers: Emerging Mediators of Drug Resistance and Promising Biomarkers
por: Lu, Zeyi, et al.
Publicado: (2023)

Exploring the Benefits of Probiotics in Gut Inflammation and Diarrhea—From an Antioxidant Perspective
por: Li, Qihui, et al.
Publicado: (2023)

Updated Perspectives on the Management of Drug-Induced Parkinsonism (DIP): Insights from the Clinic
por: Feldman, Matthew, et al.
Publicado: (2022)

HIV-1 Protease: Structural Perspectives on Drug Resistance
por: Weber, Irene T., et al.
Publicado: (2009)

Current Perspectives on HIV-1 Antiretroviral Drug Resistance
por: Iyidogan, Pinar, et al.
Publicado: (2014)

Drug-Resistant Tuberculosis and HIV Infection: Current Perspectives
por: Singh, Abhijeet, et al.
Publicado: (2020)

Alterations of gut microbiota‐derived metabolites in gestational diabetes mellitus and clinical significance
por: Gao, Yajie, et al.
Publicado: (2022)

Drug resistance: from bacteria to cancer
por: Patel, Harsh, et al.
Publicado: (2021)

Research on the Vitality Evaluation of Parks and Squares in Medium-Sized Chinese Cities from the Perspective of Urban Functional Areas
por: Wang, Tongwen, et al.
Publicado: (2022)

Expression and clinical significance of short-chain fatty acids in pregnancy complications
por: Chen, Siqian, et al.
Publicado: (2023)

Focusing on the Role of Natural Products in Overcoming Cancer Drug Resistance: An Autophagy-Based Perspective
por: Yao, Jiaqi, et al.
Publicado: (2022)

Cancer drug delivery in the nano era: An overview and perspectives
por: Li, Zhen, et al.
Publicado: (2017)

Clinical Management of HIV Drug Resistance
por: Cortez, Karoll J., et al.
Publicado: (2011)

Medical Management of Drug-Resistant Tuberculosis
por: Jeon, Doosoo
Publicado: (2015)

Colistin Resistance and Management of Drug Resistant Infections
por: Sharma, Juhi, et al.
Publicado: (2022)

The Non-Coding RNAs Inducing Drug Resistance in Ovarian Cancer: A New Perspective for Understanding Drug Resistance
por: Li, Gaofeng, et al.
Publicado: (2021)

Drug-Resistant Breast Cancer: Dwelling the Hippo Pathway to Manage the Treatment
por: Kaur, Simran, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_84p5a758namql2vs4dd1jo6opq